Fertility 101 · Free tool

Is your progesterone–estrogen balance off?

Hormone issues rarely arise from a single value. Often the problem isn’t the hormones themselves but their balance. The Pg/E2 ratio shows whether there’s enough progesterone to counter estradiol. Enter your values below to calculate it.

By Serhii Zatsarynin · Published December 1, 2025

Check my ratio

Progesterone

Estradiol (E2)

Unit reference:
Progesterone: nanograms per milliliter (ng/mL), nanomoles per liter (nmol/L).
Estradiol: picograms per milliliter (pg/mL), picomoles per liter (pmol/L).
Conversions: 1 ng/mL ≈ 3.18 nmol/L · 1 pg/mL ≈ 3.671 pmol/L. Changing a unit automatically converts the value you entered.

Note: This tool is for informational purposes only and does not replace professional medical interpretation.

What Is the Progesterone to Estrogen Ratio?

The Progesterone to Estrogen Ratio (Pg/E2) compares the concentration of progesterone (Pg) to estradiol (E2), the most biologically active form of estrogen.

Why estradiol? The body produces several estrogens (estradiol, estrone, estriol), but estradiol is the dominant and most potent estrogen in cycling women. It is therefore the primary estrogen used in clinical assessment of hormonal balance.

Purpose of the Pg/E2 Ratio

The Pg/E2 ratio helps explain how progesterone and estradiol work together across the cycle. Estradiol helps build and thicken the uterine lining. Progesterone helps stabilize and mature that lining after ovulation. In simple terms, estrogen prepares the tissue, while progesterone helps organize and calm the response.

When progesterone is too low compared with estradiol, estrogen may have a stronger effect, even if estradiol itself appears “normal.” This pattern is often discussed as estrogen dominance, meaning estrogen activity is not being properly balanced by progesterone.

When Should the Pg/E2 Ratio Be Measured?

For cycling women, the ratio is meaningful only if measured at the mid-luteal phase, typically:

5–7 days after ovulation,
around day 19–22 of a 28-day cycle.

Testing too early can be misleading. In the follicular phase, estrogen is naturally more active and progesterone is naturally low. That can create a low Pg/E2 ratio that is completely normal for that part of the cycle. For postmenopausal women, both estrogen and progesterone are naturally lower; the ratio can still be calculated, but it is interpreted differently, especially when hormone therapy is involved.

Progesterone to Estrogen Formula

To calculate the Pg/E2 ratio, both hormone concentrations must be in the same units. This is the step where most errors occur.

Pg/E2 ratio = Progesterone (Pg) ÷ Estradiol (E2) (after unit conversion)

Example: Progesterone 20,000 pg/mL ÷ Estradiol 100 pg/mL = a Pg/E2 ratio of 200.

Progesterone to Estrogen Normal Value

When measured in the mid-luteal phase in healthy, cycling women, typical ranges are:

Progesterone (P, Pg): 11 to 29 ng/mL, or about 35 to 95 nmol/L.
Estradiol (E2): 19 to 160 pg/mL, or about 70 to 600 pmol/L.

After unit conversion, an often-cited optimal Pg/E2 ratio for healthy women during the luteal phase is 100 to 500. This means progesterone is 100 to 500 times higher than estradiol when both are measured in pg/mL, as long as estradiol itself is within the normal luteal range.

How This Ratio Is Used Clinically

100–500 → suggests an adequate progesterone “buffer” against estradiol’s effects.
<100 → suggests estrogen dominance (relative progesterone deficiency).
>500 → suggests progesterone dominance, often in the context of supplementation.

Estrogen Dominance

Estrogen dominance describes a state where estrogen’s actions are inadequately balanced by progesterone. In Pg/E2 terms, this often appears as Pg/E2 < 100. Estradiol may be normal or even low in absolute terms; the imbalance arises because progesterone is too low relative to estradiol, particularly in the luteal phase.

Common causes include anovulatory cycles (no ovulation → no corpus luteum → low progesterone), perimenopause (progesterone declines earlier and more sharply than estrogen), chronic stress (favoring cortisol over progesterone synthesis), obesity (adipose tissue converts androgens to estrogen via aromatase), and liver overload, gut dysbiosis, or exposure to xenoestrogens (BPA, phthalates, etc.).

Common symptoms of estrogen dominance (low Pg/E2): heavy or prolonged menstrual bleeding; more intense PMS or PMDD; uterine fibroids, endometriosis, tender or fibrocystic breasts; weight gain (hips, thighs, abdomen); water retention and bloating; headaches or menstrual migraines; anxiety, irritability, mood swings, “brain fog”; low libido, fatigue, poor sleep.

Progesterone Dominance

Progesterone dominance means progesterone is disproportionately high relative to estradiol, often reflected as Pg/E2 > 500. This pattern is relatively uncommon compared with estrogen dominance and is often iatrogenic — caused by high-dose progesterone or pregnenolone supplementation, rather than natural physiology (with the exception of pregnancy).

Common symptoms of progesterone dominance (high Pg/E2): fatigue, sedation, daytime sleepiness; bloating, slower digestion; low mood or emotional flattening; low libido; and in some cases signs of relative estrogen deficiency (e.g., vaginal dryness, hot flashes), especially if estrogen is already low.

Long-Term Consequences of Chronic Imbalance

Chronic unopposed estrogen (low Pg/E2 for long periods) may contribute to endometrial hyperplasia, a higher risk of certain hormone-sensitive cancers (endometrial, some breast cancers), progression of fibroids and endometriosis, and increased risk of recurrent miscarriage or implantation failure. Persistently distorted ratios can also negatively affect quality of life: pain, sleep issues, mood disorders, and sexual dysfunction.

Ratio questions, answered

Frequently asked questions

For cycling women tested in the mid-luteal phase, an often-used “good” or optimal Pg/E2 ratio is 100–500 (progesterone/estradiol, both in pg/mL). A result within this range generally suggests that progesterone sufficiently balances estradiol, assuming each hormone is also within its normal luteal phase range.

There is no single “perfect” number that applies to everyone. However, Pg/E2 between 100 and 500 is commonly considered ideal in the mid-luteal phase for healthy, cycling women. “Ideal” also depends on your symptoms, age, and clinical situation (e.g., natural cycle vs. IVF vs. hormone therapy).

In practical terms, “normal” for cycling women is Pg/E2 ≈ 100–500 during the luteal phase. Outside of this phase (e.g., follicular phase), the ratio is naturally much lower and should not be interpreted as pathological.

This is a trick of units. Estradiol is often reported in pg/mL, while progesterone is often reported in ng/mL (which is 1000× larger). So numerically, progesterone (in ng/mL) may look similar to or lower than estrogen (in pg/mL), but once both are converted to pg/mL, progesterone should be much higher than estradiol during the luteal phase. In a healthy luteal phase, progesterone should dominate over estradiol.

Symptoms suggestive of high Pg/E2 (progesterone dominance) can include excessive fatigue and daytime sleepiness; a feeling of being “slowed down” or sedated; bloating, constipation, fluid retention; low libido; and mood flattening, apathy, or irritability. If you are on progesterone or pregnenolone supplements and have these symptoms with a very high Pg/E2 ratio, discuss dose adjustment with your healthcare provider.

In a healthy luteal phase, progesterone should be dominant relative to estrogen. This is normal physiology, not a problem. However, chronic estrogen dominance (low Pg/E2) is associated with more clinically significant risks and symptoms (heavy bleeding, fibroids, endometrial changes, higher risk for some hormone-sensitive cancers). Excessive progesterone dominance is less common but can still cause unpleasant symptoms and, in postmenopausal women, can worsen low-estrogen complaints. The goal is not “more progesterone at all costs”, but a balanced ratio appropriate to your life stage and clinical context.

During perimenopause, ovulation becomes irregular → corpus luteum formation is inconsistent → progesterone falls first and most dramatically. Estradiol, although overall trending downward, can fluctuate widely and sometimes spike to higher-than-younger levels. The result: the Pg/E2 ratio naturally decreases, creating a pattern of relative estrogen dominance. This explains typical perimenopausal symptoms — heavier or erratic periods, worsening PMS and mood swings, sleep disturbances, breast tenderness, and sometimes hot flashes. (Related: Menopause Age Calculator.)

Because it reflects functional balance rather than just absolute hormone levels. The Pg/E2 ratio helps identify unopposed estrogen, which can disrupt the endometrium and menstrual pattern; suggests whether luteal phase progesterone is sufficient to support implantation; and provides additional context in cases of infertility, recurrent miscarriage, or severe PMS/PMDD. In assisted reproduction (IVF/ICSI), both progesterone and estradiol levels — and their ratio — are monitored. Some studies have found that a high estradiol-to-progesterone ratio on the day of ovulation induction is associated with higher oocyte numbers and implantation rates, while a high progesterone-to-estradiol ratio at the wrong time may signal premature endometrial maturation and reduced implantation chances.

Still have a question? Contact us →

Disclaimer

The information in this article and any associated calculator is for informational and educational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Never ignore or delay seeking professional medical advice because of something you have read here. Always consult your doctor, gynecologist, endocrinologist, or other qualified healthcare provider for personalized evaluation and treatment.

References

Ratios need context — trends provide it.

Ovul follows your estrogen trend over time, adding context to cycle symptoms, ovulation timing, and clinical testing.

Start from $149.99 HSA/FSA eligible

See estrogen fits into the balance

Track your estrogen trend before your next blood test

Ovul focuses on estrogen-induced patterns through saliva-based ferning analysis and AI. Follow your estrogen trend over time to add context to cycle symptoms, ovulation timing, and clinical testing when needed.

$149.99renews at $18.99/mo after included term

Learn about saliva estrogen tracking →

✓ Free shipping✓ 6-month money-back guarantee✓ HSA/FSA eligible